Dashboard
Manage Tickers

RAREUltragenyx Pharmaceutical Inc.

Nasdaq ultragenyx.com


$ 39.07 $ -4.07 (-9.44 %)    

Friday, 14-Jun-2024 15:59:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 39.05
$ 41.01
$ 39.03 x 100
$ 0.00 x 0
$ 38.21 - $ 41.39
$ 31.52 - $ 54.56
4,107,672
na
3.29B
$ 0.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-17-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-15-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-12-2021 12-31-2020 10-K
15 10-27-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-14-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-20-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-21-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-10-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 03-27-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session
Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

reported-earlier-ultragenyx-prices-350m-public-offering-of-7435898-common-shares-at-39share-and-pre-funded-warrants
Reported Earlier, Ultragenyx Prices $350M ...
06/14/2024 06:27:39

In addition, in lieu of issuing common stock to certain investors, the company is offering pre-funded warrants to purchase 1,53...

dave--busters-posts-downbeat-results-joins-jjill-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Dave & Buster's Posts Downbeat Results, Jo...
06/13/2024 09:51:52

ultragenyx-pharmaceutical-commences-350m-public-offering-of-common-stock-and-pre-funded-warrants
Ultragenyx Pharmaceutical Commences $350M ...
06/12/2024 20:07:39

ultragenyx-plans-to-file-for-accelerated-approval-of-ux111-for-the-treatment-of-sanfilippo-syndrome-type-a-after-meeting-with-fda
Ultragenyx Plans To File For Accelerated A...
06/12/2024 20:00:59

Agreement reached with FDA that cerebral spinal fluid (CSF) heparan sulfate (HS) can be used as a reasonable surrogate endpoint...

cantor-fitzgerald-reiterates-overweight-on-ultragenyx-pharmaceutical-maintains-115-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/12/2024 16:19:34

Cantor Fitzgerald analyst Kristen Kluska reiterates Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and maintains ...

Core News & Articles
Ultragenyx, Mereo Report 14-Month Results ...
06/11/2024 21:53:19

As of a May 24, 2024 data cut-off date, treatment with setrusumab (UX143) continued to significantly reduce incidence of fractu...

this-united-airlines-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday
This United Airlines Analyst Turns Bullish...
06/06/2024 13:58:12

goldman-sachs-upgrades-ultragenyx-pharmaceutical-to-buy-raises-price-target-to-67
Goldman Sachs Upgrades Ultragenyx Pharmace...
06/06/2024 13:03:53

Goldman Sachs analyst Salveen Richter upgrades Ultragenyx Pharmaceutical (NASDAQ:RARE) from Neutral to Buy and raises the pr...

wedbush-maintains-neutral-on-ultragenyx-pharmaceutical-raises-price-target-to-48
Wedbush Maintains Neutral on Ultragenyx Ph...
05/31/2024 17:39:50

Wedbush analyst Laura Chico maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Neutral and raises the price target fro...

b-of-a-securities-maintains-buy-on-ultragenyx-pharmaceutical-lowers-price-target-to-76
B of A Securities Maintains Buy on Ultrage...
05/31/2024 17:01:19

B of A Securities analyst Tazeen Ahmad maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and lowers the price tar...

canaccord-genuity-maintains-buy-on-ultragenyx-pharmaceutical-raises-price-target-to-111
Canaccord Genuity Maintains Buy on Ultrage...
05/31/2024 16:59:54

Canaccord Genuity analyst Whitney Ijem maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and raises the price tar...

cantor-fitzgerald-maintains-overweight-on-ultragenyx-pharmaceutical-raises-price-target-to-115
Cantor Fitzgerald Maintains Overweight on ...
05/31/2024 14:36:14

Cantor Fitzgerald analyst Kristen Kluska maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and raises the ...

peeling-back-the-layers-exploring-ultragenyx-pharmaceutical-through-analyst-insights
Peeling Back The Layers: Exploring Ultrage...
05/31/2024 14:00:47

stifel-maintains-buy-on-ultragenyx-pharmaceutical-raises-price-target-to-127
Stifel Maintains Buy on Ultragenyx Pharmac...
05/31/2024 13:28:05

Stifel analyst Dae Gon Ha maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and raises the price target from $124...

baird-maintains-outperform-on-ultragenyx-pharmaceutical-raises-price-target-to-72
Baird Maintains Outperform on Ultragenyx P...
05/31/2024 12:16:16

Baird analyst Joel Beatty maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Outperform and raises the price target fr...

ultragenyx-announces-top-line-results-from-phase-3-study-of-dtx401-gene-therapy-for-glycogen-storage-disease-type-ia
Ultragenyx Announces Top-Line Results From...
05/30/2024 20:00:59

Treatment with DTX401 resulted in a statistically significant reduction in daily cornstarch intake at Week 48 (p<0.0001) wit...

ultragenyx-faces-lawsuit-over-alleged-unjust-use-of-henrietta-lacks-cells
Ultragenyx Faces Lawsuit Over Alleged Unju...
05/22/2024 16:27:00

The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken wit...

canaccord-genuity-maintains-buy-on-ultragenyx-pharmaceutical-lowers-price-target-to-109
Canaccord Genuity Maintains Buy on Ultrage...
05/06/2024 17:35:29

Canaccord Genuity analyst Whitney Ijem maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and lowers the price tar...

cantor-fitzgerald-reiterates-overweight-on-ultragenyx-pharmaceutical-maintains-107-price-target
Cantor Fitzgerald Reiterates Overweight on...
05/03/2024 15:14:43

Cantor Fitzgerald analyst Kristen Kluska reiterates Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and maintains ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)